Results 171 to 180 of about 14,393 (219)

Treat-to-Target Strategy Achieves High Remission Rates with Sex Differences Attenuated Under Treat-to-Target Management in Rheumatoid Arthritis: A Longitudinal Analysis From the Rheumatoid Arthritis Saudi Database (RASD). [PDF]

open access: yesOpen Access Rheumatol
Almoallim HM   +15 more
europepmc   +1 more source

Proteomic and glycosylation biomarkers in rheumatoid arthritis: advancing early diagnosis and precision therapy. [PDF]

open access: yesClin Proteomics
Sharma P   +8 more
europepmc   +1 more source

Variable Domain Glycosylation of ACPA-IgG: A Missing Link in the Maturation of the ACPA Response?

open access: yesClinical Immunology, 2018
Anti-citrullinated Protein Antibodies (ACPA) are excellent markers for Rheumatoid arthritis (RA) and are postulated to have a pathogenic role in the disease process. A multistep model for the evolution of the ACPA response in RA was proposed in which an initial break of tolerance causes, as "first hit", "silent" production of ACPA without any clinical ...
Hans Ulrich Scherer   +2 more
exaly   +4 more sources

Clinical Presentation and Treatment Response in ACPA-Negative Rheumatoid Arthritis

open access: yesJoint Bone Spine
International audienceRheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation and potential extra-articular manifestations.
Divi Cornec, Baptiste Chevet
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Comparison of serological markers between ACPA+ and ACPA− of RA patients

Rheumatology International, 2011
Anti-citrullinated protein/peptide antibodies (ACPA) have recently emerged as sensitive and specific serological markers of rheumatoid arthritis (RA), providing superior alternative of the rheumatoid factor (RF) test in the laboratory diagnostics of RA. We compare the change of serum RF, CRP, IgG, IgM, IgA, total complement, C3 and C4.
Chunhua, Xun, Yong, Zhao
openaire   +2 more sources

Home - About - Disclaimer - Privacy